QualityStocksNewsBreaks Archives - Page 574 of 1571

TuesdayMay 24, 2022 3:39 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Featured in The Alden Report Interview, Announced Details of Annual Meeting

Knightscope’s (NASDAQ: KSCP) Chairman and CEO, William Santana Li, was featured on a recent episode of The Alden Report, a podcast series aimed at supporting wellness and self-improvement. During the interview, Li discussed Knightscope and the significant societal need it is addressing with its autonomous security robots. “There are a million security guards and a million law enforcement professionals… You typically need four people to cover a 24/7 post, so, at any given time, there’s only 500,000 people trying to secure 328 million Americans across 50 states. That math doesn’t work,” Li said. “[Knightscope’s autonomous security robots] are designed to…

TuesdayMay 24, 2022 2:18 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Shares Company Presentations, Keynote Addresses from 2022 Sequire Fintech Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, is making replays from its 2022 Sequire Fintech Conference presentation available. SRAX hosted the virtual investor event on May 19, 2022. During the conference, premier fintech stock market companies made key presentations to investor attendees; industry experts also provided keynote addresses during the event. The event was sponsored by Apex Fintech Solutions, Banxa Holdings Inc., Usio Inc. and Newtek Business Services Corp. According to the announcement, those interested can view the keynote address, panel discussions and company presentations…

TuesdayMay 24, 2022 11:25 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Schedules Conference Call to Discuss Q1 2022 Financial Results, Enters Acquisition Agreement

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, will releases its 2022 first-quarter financial results after market close today, May 24, 2022. In addition, the company will host a Zoom conference call to discuss company financial results and corporate updates on Wednesday, May 25. The Zoom event will begin at 10 a.m. ET. EverGen CEO Chase Edgelow will lead the call. In addition, EverGen signed a definitive agreement to acquire 50% interest in a portfolio of RNG development projects, known as Project Radius and owned by Northeast Renewables LP. The acquisition gives EverGen entry into the…

TuesdayMay 24, 2022 10:35 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at H.C. Wainwright Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its CEO John Climaco will be participating at the H.C. Wainwright Global Investment Conference. The event is slated to take place May 23-26, 2022, virtually and in-person in Miami, Florida. A video webcast of Climaco’s presentation is now accessible for viewing on-demand for registered attendees and will be available on the company’s website. Following the event, the webcast replay will be archived for 90 days. In addition, CNSP management will be…

MondayMay 23, 2022 1:47 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Among Most Powerful of Chemotherapy Drugs

CNS Pharmaceuticals’ (NASDAQ: CNSP) novel anthracycline Berubicin, which has been developed to treat diseases with unmet need such as the deadly glioblastoma (“GBM”), appears to be the first anthracycline chemotherapy agent to successfully cross the blood-brain barrier in targeting tumors of the central nervous system. “Berubicin was the drug candidate subject of a small-scale phase 1 clinical trial in 2006 that evaluated its safety, which was notable because one of the two dozen evaluated patients emerged cancer-free and has remained so over the subsequent 16 years. Nearly half of the trial’s patients experienced a statistically significant improvement in clinical benefit.…

MondayMay 23, 2022 1:38 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope to Patients Suffering from Alzheimer’s and Potentially Other Ailments

Silo Pharma (OTCQB: SILO) is exploring the efficacy of ketamine in treating patients suffering from both Alzheimer’s and Parkinson’s disease. With more than 80% of Parkinson’s patients and 75% of Alzheimer’s patients experiencing dysphagia, difficulty or complete inability to swallow, last year, SILO entered into a joint venture with Zylö Therapeutics. Under the collaboration, the companies will explore an innovative technology – ZTI’s Z-pod transdermal technology – to develop a ketamine delivery system for those suffering from dysphagia. “In October 2021, Silo entered into a sponsored research agreement with Columbia University incorporating the work of Dr. Christine Ann Denny. According…

MondayMay 23, 2022 1:00 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Partners to Help Accelerate Regulatory Pathway of CYB003

Cybin (NYSE American: CYBN) (NEO: CYBN) is moving forward with its phase 1/2a clinical trial of its proprietary deuterated psilocybin, CYB003, which, previous research shows, has the potential to effectively treat major depressive disorder (“MDD”) with significant advantages over classic psilocybin. MDD impacts over 264 million people worldwide, 1/3 to 1/2 of whom demonstrate an inadequate response to antidepressant drug treatment. Against this backdrop, Cybin focuses on finding solutions for those whose lives are impacted by MDD and other mental and emotional disorders. “The company recently completed in vivo preclinical studies of CYB003. The company plans to file an investigational…

MondayMay 23, 2022 12:43 pm

QualityStocksNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Suited to Build More Resilient Food Production Capabilities

Advanced Container Technologies (OTC: ACTX) is ideally situated to help meet the needs of the new U.S. Department of Agriculture’s (“USDA”) Local Food Purchase Assistance Cooperative Agreement Program (“LFPA”), which sets out to build a new and more equitable food system. The LFPA is intended to enable “state, tribal and local entities to purchase food more efficiently from local producers and invest in infrastructure that enables partner organizations to reach underserved communities more effectively,” a recent article reads. “According to Advanced Container Technologies, its GrowPods – modular hydroponic greenhouses – could become a valuable tool in this effort to build…

MondayMay 23, 2022 12:32 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Sapientia Taking over Snack Food Market One Product at a Time

Eat Well Investment Group’s (CSE: EWG) (OTC: EWGFF) Sapientia Technology LLC subsidiary, a food technology portfolio enterprise acquired in June 2021, launched its first white-label, better-for-you plant-based twisted curls in December 2021. “This specific product, the Co-op Gold PURE Plant-Based Protein Twists, would be sold in over 300 Federated Co-op stores across Western Canada as well as secure finalist status in the 29th annual Canadian Grand Prix New Product Awards… The product launch was a move by Sapientia to disrupt the multibillion-dollar snack food market by offering taste and nutrition ‘without compromise.’ Winning the finalist status at the recent Canadian Grand…

MondayMay 23, 2022 11:01 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Acquisition of Masaya CB Brand

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, has signed an agreement to acquire Masaya and its patent-pending CBD formulations, including Masaya Pure. The agreement was made with leading cell biologist Dr. Annabelle Manalo-Morgan, PhD, who created and owns the brand; Manalo-Morgan is a member of Flora Growth’s board of directors and is the company’s scientific advisor. According to the announcement, Masaya’s exclusive CBD oil formulations contain no THC and have garnered numerous testimonials. The brand will be the first offering from Flora Life Sciences in the United States, and the…

Site Search

Company Search

Category: QualityStocksNewsBreaks